70 related articles for article (PubMed ID: 12215225)
1. What have cellular models taught us about ALS?
Shaw C
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):55-6. PubMed ID: 12215225
[No Abstract] [Full Text] [Related]
2. Superoxide dismutase: the cause of all amyotrophic lateral sclerosis?
Matias-Guiu J; Galan L; Garcia-Ramos R; Barcia JA
Ann Neurol; 2008 Sep; 64(3):356-7; author reply 358. PubMed ID: 18350588
[No Abstract] [Full Text] [Related]
3. Neuroscience. Astrocytes secrete substance that kills motor neurons in ALS.
Holden C
Science; 2007 Apr; 316(5823):353. PubMed ID: 17446359
[No Abstract] [Full Text] [Related]
4. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
5. Is ALS caused by an altered oxidative activity of mutant superoxide dismutase?
Bush AI
Nat Neurosci; 2002 Oct; 5(10):919; author reply 919-20. PubMed ID: 12352974
[No Abstract] [Full Text] [Related]
6. [ALS models by transgenic animals].
Aoki M; Nagai M; Kato M; Itoyama Y
No To Shinkei; 2001 Sep; 53(9):799-807. PubMed ID: 11596474
[No Abstract] [Full Text] [Related]
7. A novel SOD mutant and ALS.
Orrell R; de Belleroche J; Marklund S; Bowe F; Hallewell R
Nature; 1995 Apr; 374(6522):504-5. PubMed ID: 7700376
[No Abstract] [Full Text] [Related]
8. Superoxide dismutase may lead to cytoskeletal abnormalities and amyotrophic lateral sclerosis.
Brenner S
Ann Neurol; 2008 Sep; 64(3):357-8; author reply 358. PubMed ID: 18409199
[No Abstract] [Full Text] [Related]
9. Determinants of rapid disease progression in ALS.
Yamanaka K; Cleveland DW
Neurology; 2005 Dec; 65(12):1859-60. PubMed ID: 16380607
[No Abstract] [Full Text] [Related]
10. Do posttranslational modifications of CuZnSOD lead to sporadic amyotrophic lateral sclerosis?
Bredesen DE; Ellerby LM; Hart PJ; Wiedau-Pazos M; Valentine JS
Ann Neurol; 1997 Aug; 42(2):135-7. PubMed ID: 9266721
[No Abstract] [Full Text] [Related]
11. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
[TBL] [Abstract][Full Text] [Related]
12. Human genetics. Did radicals strike Lou Gehrig?
McNamara JO; Fridovich I
Nature; 1993 Mar; 362(6415):20-1. PubMed ID: 8383294
[No Abstract] [Full Text] [Related]
13. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
Gonzalez de Aguilar JL; Dupuis L; Oudart H; Loeffler JP
Biomed Pharmacother; 2005 May; 59(4):190-6. PubMed ID: 15862714
[TBL] [Abstract][Full Text] [Related]
14. Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide dismutase gene mutation.
Tan CF; Piao YS; Hayashi S; Obata H; Umeda Y; Sato M; Fukushima T; Nakano R; Tsuji S; Takahashi H
Acta Neuropathol; 2004 Oct; 108(4):332-6. PubMed ID: 15235802
[TBL] [Abstract][Full Text] [Related]
15. Are all new data referring to amyotrophic lateral sclerosis certain? Some doubts.
Rafałowska J
Folia Neuropathol; 2001; 39(4):261-4. PubMed ID: 11928897
[TBL] [Abstract][Full Text] [Related]
16. Lack of apoptosis in mice with ALS.
Migheli A; Atzori C; Piva R; Tortarolo M; Girelli M; Schiffer D; Bendotti C
Nat Med; 1999 Sep; 5(9):966-7. PubMed ID: 10470053
[No Abstract] [Full Text] [Related]
17. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice.
Brown RH
Cell; 1995 Mar; 80(5):687-92. PubMed ID: 7889564
[No Abstract] [Full Text] [Related]
18. Matrix metalloproteinases--a conceptional alternative for disease-modifying strategies in ALS/MND?
Ludolph AC
Exp Neurol; 2006 Oct; 201(2):277-80. PubMed ID: 16808915
[No Abstract] [Full Text] [Related]
19. Motor neuron disease: The curious ways of ALS.
Polymenidou M; Cleveland DW
Nature; 2008 Jul; 454(7202):284-5. PubMed ID: 18633404
[TBL] [Abstract][Full Text] [Related]
20. RNA interference protects against ALS in mouse model.
Burton A
Lancet Neurol; 2005 May; 4(5):274-5. PubMed ID: 15861555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
